Cardiovascular side effects Another area of concern with retatrutide is its potential impact on the cardiovascular system
2026 Guidance: In its most recent earnings call, DaVita shocked the market by projecting 2026 adjusted EPS of $13.60 to $15.00 (midpoint $14.30), well above the $12.65 analyst consensus
Recent postmarketing data (reports from people whove used the medication since it became available for use) has also identified more serious complications , including ileus (a type of intestinal blockage) and severe constipation leading to fecal impaction
Combining it with meloxicam produced Zynrelef, designed to relieve postoperative pain in adult patients who have undergone surgery, such as a bunionectomy, open inguinal herniorrhaphy or total knee arthroplasty
If you would like to meet in-person with a member of our Medspa team, please call the location of your choice or click the button below to request an in-person GLP-1 Weight Loss consultation